Readers had a lot to say about my latest column on the Food and Drug Administration’s proposed front-of-package labels. Most ...

Debate over labeling certain cancers as 'benign' or 'premalignant' instead of 'cancer' due to stigma and fear. Experts weigh in on potential impact ...